Skip to main content

Complications of Intrathecal Drug Delivery

  • Chapter
  • First Online:
Atlas of Implantable Therapies for Pain Management

Abstract

Intrathecal pumps are an option that allows patients who suffer from moderate-to-severe pain to have an improvement in quality of life, reduction in pain, and change in function. They also are an option for patients who are at the end of life to improve alertness, reduce fatigue and nausea, and improve survival. Unfortunately, despite the many positive attributes of these devices, they are not without risks. The complications can be classified as surgical, device related or drug related. This chapter focuses on the complications of intrathecal drug delivery, and on options to assess and reduce risks.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  1. Harney D, Victor R. Traumatic syrinx after implantation of an intrathecal catheter. Reg Anesth Pain Med. 2004;29(6):606–609.

    PubMed  Google Scholar 

  2. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain. 2004;109(3):242–249.

    Article  PubMed  CAS  Google Scholar 

  3. Coffey RJ, Burchiel KJ. Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery. 2002;50(1): in press.

    Google Scholar 

  4. Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology. 2003;99(1):174–187.

    Article  PubMed  CAS  Google Scholar 

  5. Huntoon MA, Hurdle MF, Marsh RW, Reeves RK. Intrinsic spinal cord catheter placement: implications of new intractable pain in a patient with a spinal cord injury. Anesth Analg. 2004;99(6):1763–1765. table of contents.

    Article  PubMed  Google Scholar 

  6. Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage. 2000;19(3):209–215.

    Article  PubMed  CAS  Google Scholar 

  7. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage. 1996;11(2):71-80.

    Article  PubMed  CAS  Google Scholar 

  8. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg. 1996;85(3):458–467.

    Article  PubMed  CAS  Google Scholar 

  9. Deer T. A prospective analysis of intrathecal granuloma in chronic pain patients. A review of the literature and report of a surveillance study. An original contribution. Pain Physician. 2004;7:225–228.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy R. Deer .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Deer, T.R. (2011). Complications of Intrathecal Drug Delivery. In: Atlas of Implantable Therapies for Pain Management. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88567-4_28

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-88567-4_28

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-88566-7

  • Online ISBN: 978-0-387-88567-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics